Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emifarma is an Italian pharmaceutical company and contract development and manufacturing organization (CDMO) specializing in liquid and semi-solid formulations. Founded in 1983 and headquartered in Mulazzano, the company provides comprehensive services for the production of medicinal products, medical devices, and food supplements. Their capabilities include formulation development, analytical testing, and large-scale industrial manufacturing of creams, gels, syrups, and oral drops. Emifarma operates under strict Good Manufacturing Practice (GMP) standards and holds various ISO certifications to ensure high-quality output for its international client base. The company is a key player in the European outsourcing market for topical and oral healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emifarma.